# Prevalence of Anticipatory Nausea and Vomiting in Cancer Patients Exposed to Highly Emetogenic Chemotherapy

> **NCT04785495** · — · UNKNOWN · sponsor: **Instituto Brasileiro de Controle do Cancer** · enrollment: 50 (estimated)

## Conditions studied

- Chemotherapy-induced Nausea and Vomiting

## Interventions

- **OTHER:** Quality-of-life assessment

## Key facts

- **NCT ID:** NCT04785495
- **Lead sponsor:** Instituto Brasileiro de Controle do Cancer
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-12
- **Primary completion:** 2021-08
- **Final completion:** 2021-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04785495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04785495, "Prevalence of Anticipatory Nausea and Vomiting in Cancer Patients Exposed to Highly Emetogenic Chemotherapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04785495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*